Targeted Fat Metabolism Support
AOD-9604 is a modified fragment of human growth hormone (HGH) specifically designed to target fat metabolism without the side effects associated with full HGH therapy. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation).
Join the waitlist and we'll notify you the moment physician-guided AOD-9604 therapy becomes available through Zelvimed.
No spam. Unsubscribe anytime. We'll only email you when AOD-9604 becomes available.
What the research says about Anti-Obesity Drug 9604
AOD-9604 targets the fat-burning region of growth hormone, stimulating the breakdown of stored fat while inhibiting new fat formation — without affecting blood sugar or growth.
Unlike full growth hormone therapy, AOD-9604 does not raise IGF-1 levels, meaning it avoids the proliferative risks associated with HGH.
Studies suggest AOD-9604 may help improve body composition by selectively reducing adipose tissue while preserving lean muscle mass.
Emerging research indicates AOD-9604 may also support cartilage regeneration, with potential applications in osteoarthritis treatment.
Individuals focused on body composition, those looking for growth-hormone-fragment-based fat loss support, and people interested in metabolic optimization.
When AOD-9604 becomes available, demand will be high. Get on the waitlist now to secure early access to physician-guided therapy through Zelvimed.
Join 0 others waiting for AOD-9604 access.